Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
218600-44-3
Purity
95%
Bardoxolone is a drug under investigation that has been studied for the treatment of cancer, specifically lymphoma. It is a potential activator of apoptosis in cancer cells that experience oxidative stress
Properties
Name
Bardoxolone
Smiles
CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)C(=C[C@@]54C)C#N)C(=O)O
Targets
Please log in to see this information
2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid | 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid | CDDO | bardoxolone
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$132
2 mg
$138
5 mg
$150
10 mg
$166
15 mg
$234
20 mg
$302
25 mg
$374
30 mg
$422
35 mg
$470
40 mg
$512
45 mg
$564
50 mg
$606
75 mg
$886
100 mg
$1000
Quantity
1
Total amount
$ 150
2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid | 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid | CDDO | bardoxolone
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.